trial
as of 2026-07-01Cannabinoids and Cerebellar-Motor Functioning
NCTId NCT01853020
at a glance
Early Phase 1 · Completed
Enrollment 57 (actual)
Sponsored by Yale University
Primary completion 2015-04-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Early Phase 1
Status
Completed
Enrollment
57 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2012-12
Primary completion
2015-04-07
Eligibility
ALL · 21 Years · 35 Years
Interventions & indications
Drugs
Sponsors
Yale UniversityLead Sponsor
Sites
1 total
West Haven, United States
Facts & assertions
4 sourced
Enrollment
57
Phase
EARLY_PHASE1
Primary Completion Date
2015-04-07
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication